guest ::
| Home > Publications database > Conditional Survival in Prostate Cancer in the Nordic Countries Elucidates the Timing of Improvements. |
| Home > Publications database > Conditional Survival in Prostate Cancer in the Nordic Countries Elucidates the Timing of Improvements. |
| Journal Article | DKFZ-2023-01736 |
; ; ; ;
2023
MDPI
Basel
This record in other databases: 
Please use a persistent id in citations: doi:10.3390/cancers15164132
Abstract: The incidence of prostate cancer (PC) increased vastly as a result of prostate-specific antigen (PSA) testing. Survival in PC improved in the PSA-testing era, but changes in clinical presentation have hampered the interpretation of the underlying causes.We analyzed survival trends in PC using data from the NORDCAN database for Denmark (DK), Finland (FI), Norway (NO) and Sweden (SE) by analyzing 1-, 5- and 10-year relative survival and conditional relative survival over the course of 50 years (1971-2020).In the pre-PSA era, survival improved in FI and SE and improved marginally in NO but not in DK. PSA testing began toward the end of the 1980s; 5-year survival increased by approximately 30%, and 10-year survival improved even more. Conditional survival from years 6 to 10 (5 years) was better than conditional survival from years 2 to 5 (4 years), but by 2010, this difference disappeared in countries other than DK. Survival in the first year after diagnosis approached 100%; by year 5, it was 95%; and by year 10, it was 90% in the best countries, NO and SE.In spite of advances in diagnostics and treatment, further attention is required to improve PC survival.
Keyword(s): PSA screening ; periodic survival ; prognosis ; treatment
; 
; 
; Article Processing Charges ; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; DOAJ Seal ; Ebsco Academic Search ; Essential Science Indicators ; Fees ; IF >= 5 ; JCR ; PubMed Central ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
|
The record appears in these collections: |
